HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

Fisher & Paykel to Construct Fifth Building in New Zealand
The new facility is expected to open in 2027.

March 6, 2025 by Laurie Watanabe

Artist's rendering shows a large building with a parking lot, from above.

Artist’s rendering of the upcoming fifth Fisher & Paykel building.

Fisher & Paykel Healthcare Corp. (NZX: FPH) is planning to construct a fifth building on its East Tāmaki campus in Auckland, New Zealand.

“We are excited to add this new building to complete our East Tāmaki campus,” said Andy Niccol, Fisher & Paykel’s chief operating officer in a March 6 announcement. “This project is a purposeful investment in infrastructure to ensure we have the necessary capacity and resources in New Zealand to progress our pipeline of innovative products and therapies.”

The new facility will be approximately 301,000 square feet (28,000 square meters) and “will showcase a cohesive blend of spaces for research and development, manufacturing and distribution,” the announcement said. The estimated cost of building the facility is more than $143 million U.S. ($250 million New Zealand).

The East Tāmaki campus currently has nearly 4,000 employees “and the new building will accommodate the company’s expected growth in Auckland over the next five years,” Fisher & Paykel said. The new building should be operational in 2027.

Fisher & Paykel, which operates in the respiratory care and sleep apnea spaces, is also planning to expand its Karaka, Auckland campus, the announcement said.

Image courtesy Fisher & Paykel Healthcare Corp.

Related Articles Read More >

NCPA Announces New Senior Vice President of the Office of CEO
Sara Roszak is an industry veteran who most recently served at the National Association of Chain Drug Stores.
More HCPCS Codes to Be Added to Medicare Prior Authorization Process in October
Prior authorization will be required for eight additional codes for dates of service of Oct. 28 and later.
M&A Update, Part 2: What Makes a Good Investment or Acquisition?
At the HME Business FUTURE conference, experts on mergers and acquisitions took the stage.
Frazier Healthcare Acquires MatrixCare, Appoints CEO
MatrixCare was owned by Resmed.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe